| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441517 | European Journal of Cancer | 2016 | 9 Pages |
Abstract
The increase in NAC administration in the Netherlands reflects a slow but steady adoption of evidence-based guidelines over the last two decades. Considerable variability in patients' and hospital characteristics in the likelihood of receiving NAC exists. Conversely, NAR, AR and AC are hardly administered anymore.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tom J.N. Hermans, Elisabeth E. Fransen van de Putte, Simon Horenblas, Valery Lemmens, Katja Aben, Michiel S. van der Heijden, Laurens V. Beerepoot, Rob H. Verhoeven, Bas W.G. van Rhijn,